|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0001645,
umls-concept:C0003811,
umls-concept:C0021149,
umls-concept:C0032143,
umls-concept:C0155626,
umls-concept:C0237881,
umls-concept:C0332293,
umls-concept:C0450442,
umls-concept:C0750502,
umls-concept:C1280500,
umls-concept:C1442770
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1994-4-13
|
|
pubmed:abstractText |
Although early intravenous beta-blocker therapy during acute myocardial infarction (AMI) reduces the incidence of fatal arrhythmias in patients not treated with thrombolytic agents, its antiarrhythmic effect in thrombolysed patients remains controversial. We investigated prospectively the arrhythmia incidence in 244 patients with AMI receiving alteplase and a double-blind randomized adjunctive therapy with intravenous atenolol, alinidine, or placebo. Moreover, the characteristics and prognostic significance of early arrhythmias and their relation with infarct size and coronary patency were evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1051-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8124790-Anti-Arrhythmia Agents,
pubmed-meshheading:8124790-Arrhythmias, Cardiac,
pubmed-meshheading:8124790-Atenolol,
pubmed-meshheading:8124790-Clonidine,
pubmed-meshheading:8124790-Double-Blind Method,
pubmed-meshheading:8124790-Electrocardiography, Ambulatory,
pubmed-meshheading:8124790-Female,
pubmed-meshheading:8124790-Humans,
pubmed-meshheading:8124790-Incidence,
pubmed-meshheading:8124790-Male,
pubmed-meshheading:8124790-Middle Aged,
pubmed-meshheading:8124790-Myocardial Infarction,
pubmed-meshheading:8124790-Prognosis,
pubmed-meshheading:8124790-Prospective Studies,
pubmed-meshheading:8124790-Thrombolytic Therapy,
pubmed-meshheading:8124790-Time Factors,
pubmed-meshheading:8124790-Tissue Plasminogen Activator
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.
|
|
pubmed:affiliation |
Department of Cardiology, University of Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
